Research paperZika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement
Under a Creative Commons license
open access
Keywords
Zika virus vaccine
VLPs
Nanoparticles
Pichia pastoris;Dengue virus
Antibody-dependent enhancement
AG129
C57BL/6 Stat2−/−
Cited by (0)
- 1
These authors contributed equally.
- 2
Current address: Vaccine R & D, R & D-III, Sun Pharmaceutical Industries Ltd., Gurugram, India.
© 2020 The Authors. Published by Elsevier B.V.